Navigation Links
New Antibiotic May Treat Skin Infections in Shorter Time
Date:2/12/2013

TUESDAY, Feb. 12 (HealthDay News) -- A short course of treatment with a newer antibiotic called tedizolid works as well against bacterial skin infections as longer treatment with the antibiotic linezolid, a new study finds.

"These infections, which include cellulitis and other wound infections, can be life threatening," noted one expert not connected to the study, Dr. Michele Green, a dermatologist at Lenox Hill Hospital, in New York City. "Because so many of these infections have become antibiotic-resistant, the development of a novel antibiotic which is effective is very important," she added.

The new phase 3 clinical trial included 667 adult patients in North America, Latin America and Europe who received either 200 milligram pills once a day of tedizolid phosphate for six days, or 600 mg of linezolid every 12 hours for 10 days.

The drugs showed similar levels of effectiveness after two to three days and after 11 days, according to the study in the Feb. 13 issue of the Journal of the American Medical Association.

Side effects, mostly mild or moderate, occurred in nearly 41 percent of patients taking tedizolid and about 43 percent of those taking linezolid. Rates of serious side effects were low and similar in both groups, according to a journal news release.

The study was led by Dr. Philippe Prokocimer, of Trius Therapeutics Inc., San Diego, which makes tedizolid and funded the study.

According to Green, the study suggests tedizolid is "a reasonable alternative" to the older drug, especially for infections with MRSA (methicillin-resistant Staphylococcus aureus), "which is a growing problem, due to antibiotic resistance and the continued use of prolonged antibiotics."

Another expert agreed. Dr. Scott Gorenstein is an expert in wound healing therapies at Winthrop-University Hospital in Mineola, N.Y. He said it is important to find shorter-course antibiotic therapies to help reduce antibiotic resistance and the risk for complications.

Gorenstein, who is also clinical director of the hospital's Hyperbaric Medicine Program, called the study "a great starting point" for further research to confirm these findings.

More information

MedlinePlus has more about skin infections.

-- Robert Preidt

SOURCE: Michele Green, M.D., dermatologist, Lenox Hill Hospital, New York City; Scott Gorenstein, M.D., clinical director, Hyperbaric Medicine Program, Winthrop-University Hospital, Mineola, N.Y.; Journal of the American Medical Association, news release, Feb. 12, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Antibiotics Linked to Retinal Detachment Risk
2. Researchers find evidence of banned antibiotics in poultry products
3. Study Finds Antibiotics Best for Appendicitis
4. FDA Seeks to Limit Antibiotics in Animal Feed
5. Probiotic Products May Prevent Antibiotic-Linked Diarrhea
6. Study Links Antibiotic to Slight Rise in Heart Patients Death Risk
7. Study shows antibiotic improves respiratory function in lung transplant patients
8. Antibiotic-Resistant Gonorrhea Spreading: WHO
9. A non-antibiotic approach for treating urinary tract infections
10. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
11. Study examines role of seasonal prescribing changes in antibiotic resistance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Antibiotic May Treat Skin Infections in Shorter Time
(Date:6/28/2017)... ... June 28, 2017 , ... Schneider Insurance ... assistance to clients in southern Montana, is announcing a focused charity effort to ... The outreach programs offered by Zoo Montana provide students with current knowledge on ...
(Date:6/28/2017)... ... June 28, 2017 , ... Designers ... to communities in northern Virginia and DC, is announcing a cooperative charity event ... with Alzheimer’s and other disorders that lead to memory impairment. , The Insight ...
(Date:6/27/2017)... ... 27, 2017 , ... Excel Medical, the leader in Next-Generation ... of Executive Vice President, Sales and Marketing. Finnegan is a widely known industry ... sales leadership. He has received industry recognition for innovations and new approaches to ...
(Date:6/27/2017)... PA and London UK (PRWEB) , ... June 27, 2017 , ... ... applying to a clinical study is whether they can trust the sponsor to pay ... it is vital that sponsors and CROs establish payment strategies that encourage sites to ...
(Date:6/27/2017)... ... 27, 2017 , ... Salucro, the cloud-based payment platform that ... hospitals and provider groups, has announced that it will now offer Parasail’s payment ... a San Francisco health-finance startup that has launched a series of tech-based products ...
Breaking Medicine News(10 mins):
(Date:6/3/2017)...  Eli Lilly and Company (NYSE: ... Phase 3 MONARCH 2 study showed that abemaciclib, ... combination with fulvestrant, significantly improved progression-free survival (PFS) ... with hormone-receptor-positive (HR+), human epidermal growth factor receptor ... or progressed after endocrine therapy (median PFS, 16.4 ...
(Date:5/30/2017)... May 30, 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading ... today announced that it will be presenting at the 7th annual ... PT. Erez Raphael , CEO, of DarioHealth will be giving ... be held on June 6th & 7th, 2017 at the Luxe ... small / micro-cap space. About ...
(Date:5/29/2017)... 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... enables the functional selection of stem cells, today provided ... first quarter ended March 31 st , 2017. ... in the first quarter of 2017," said Dr. Shai ... announced the treatment of the first blood cancer patient ...
Breaking Medicine Technology: